The Rapid Advancements In Gene Therapy Tools Anticipated To Openup The New Avanue For Achondroplasia Treatment Market
Achondroplasia is the most common form of short-limbed dwarfism caused by a mutation or defects in fibroblast growth factor receptor 3 (FGFR3) which lead to bone growth failure. Current treatments for achondroplasia focus on treating complications and symptoms. However, recent advancements in understanding the molecular mechanisms and genetic causes of achondroplasia have opened avenues for...
0 Comments 0 Shares 481 Views 0 Reviews